Segra International to Launch 2nd Plant Tissue Culture Lab Program in California

October 28, 2021

VANCOUVER, BC (October 28, 2021) – Segra International Corp., an agriculture technology company, is pleased to announce its 2nd strategic "Satellite Lab" partnership in California with a "Top 5" greenhouse producer ("the producer").

Under the terms of Segra's Satellite Lab program, the company will provide strategic lab design and management services to develop a state-of-the-art plant tissue culture program on-site at the producer's facility, one of California's largest and most reputable licensed greenhouse operations.

Once complete, the lab will have the capacity to regenerate and prepare numerous high-value cultivars for production. Construction is currently underway, with operations planned to commence in December.

"This collaboration represents Segra's second partnership in California, said Jamie Blundell, Segra's Chief Executive Officer. We continue to see strong interest in our "Satellite Lab" programs, where large-scale US producers can take full advantage of our suite of technologies and expertise under bespoke partnership agreements. Segra's tissue culture processes, pathogen detection tests, and quality control systems represent the emerging gold standard for modern Cannabis nursery operations. With the pathogen management challenges virtually all large-scale Cannabis producers are currently facing, having continuous access to standardized, clean stock young plants represents an enormous competitive advantage for Satellite Lab program participants."

To learn more about Segra's Satellite Labs program, contact growth@segra-intl.com


About Segra International:
Segra is an agriculture technology company offering plant tissue culture, plant genomics, and pathogen detection services to accelerate the advancement of the cannabis industry. Its proprietary technologies empower its clients to drive financial performance and mitigate risk while exploring the next frontier of optimized cultivation practices for the rapidly evolving cannabis consumer. Segra has developed industrial-scale laboratories to produce Verified Segra Stock™, robust, and DNA-fingerprinted cannabis plantlets for licensed producers globally. Segra has assembled a world-class team of specialists in the fields of agronomy, molecular genetics, plant tissue culture, and regulatory compliance to support this vision. Learn more at segra-intl.com or view the 2021 Cultivar and Services Catalogue.


Contact For Further Information

‍Carson Otto

Carson.otto@segra-intl.com

‍Forward-Looking Information‍

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.